Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dog Allergen Extract
- Development stage
- Phase 4
- Lead developer
- Jubilant HollisterStier
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Percutaneous
01
Overview
Dog allergen extract is used for the diagnosis and treatment of allergies to dog dander and hair. It is administered through subcutaneous injection for immunotherapy and percutaneous use for diagnosis. The extract contains proteins such as Can f 1, which is crucial for effective diagnosis and treatment.
- Brand names
- AP Dog
- Other names
- Dog Hair and Dander Extract
Beyond the preview
Go deeper on Dog Allergen Extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dog Allergen Extract.